Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

Examination of the interactions of the amyloid precursor protein carboxyl terminus to intracellular protein: possible role in apoptosis

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Toxic Effect of Carboxyl-Terminal Peptide of Β-Amyloid Precursor Protein (APPC31) on Neuro2a Cells

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity: Microglia-mediated oxidative neurotoxicity

The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment

Amyloid Precursor Protein Revisited

Appoptosin Interacts with Amyloid Precursor Protein and Mediates Neuronal Toxicity Via Caspase Depended Pathway

The Effects of Gm1 on Conformational Changes of the N-Terminus of App

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

The amyloid precursor protein: beyond amyloid

A Toxicogenic Interaction between Intracellular Amyloid-β and Apolipoprotein-E

The Effects of Extracellular Serum Concentration on APP Processing in Npc1-Deficient APP-Overexpressing N2a Cells

APP Substitutions V715F and L720P Alter PS1 Conformation and Differentially Affect Abeta and AICD Generation.

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

APP and β-amyloid modulate protein aggregation and dissociation from recycling endosomal and exosomal membranes

Advances in the β-amyloid precursor protein of Alzheimer's disease

Cellular and Molecular Basis of Beta-Amyloid Precursor Protein Metabolism